SYSTEMIC SCLEROSIS (SSC)
Clinical trials for SYSTEMIC SCLEROSIS (SSC) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS (SSC) trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS (SSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells aim to tame autoimmune attacks
Disease control TerminatedThis early-phase trial tests a new cell therapy called BEN301 for several autoimmune diseases, including scleroderma and rheumatoid arthritis. The therapy uses specially engineered immune cells (CAR-Treg cells) to calm the overactive immune system. The study involves 24 adults an…
Matched conditions: SYSTEMIC SCLEROSIS (SSC)
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with autoimmune diseases like lupus, scleroderma, and vasculitis. Prula-cel uses donor immune cells engineered to target and destroy faulty immune cells that attack the body. The goal is to find a safe dose …
Matched conditions: SYSTEMIC SCLEROSIS (SSC)
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Promising autoimmune therapy trial pulled before it even started
Disease control TerminatedThis study was designed to test a new treatment for people with autoimmune diseases like lupus, scleroderma, and myositis. It combined a specially engineered immune cell product (CLBR001) with a targeted antibody drug (SWI019), with or without a preparatory chemotherapy step. How…
Matched conditions: SYSTEMIC SCLEROSIS (SSC)
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can online therapy help scleroderma patients manage daily life?
Symptom relief OngoingThis pilot study tests whether a personalized online occupational therapy program is feasible and helpful for adults with scleroderma. Twenty-four participants in Spain will either receive eight online therapy sessions over four weeks plus usual care, or usual care alone. The stu…
Matched conditions: SYSTEMIC SCLEROSIS (SSC)
Phase: NA • Sponsor: Universidad de Zaragoza • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New study checks if hand disability survey works for turkish scleroderma patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if a questionnaire called HDISS-DU, which measures hand disability caused by digital ulcers in people with systemic sclerosis (scleroderma), is valid and reliable in Turkish. About 72 adults with scleroderma will fill out the questionnaire along with other …
Matched conditions: SYSTEMIC SCLEROSIS (SSC)
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New hand health survey for scleroderma patients tested in turkish
Knowledge-focused ENROLLING_BY_INVITATIONThis study checks if a questionnaire called the Hand ScleroDerma Lived Experience Scale (HAnDE Scale) works well for Turkish-speaking people with systemic sclerosis. Researchers will ask 54 participants to fill out the survey and perform hand movement tests. The goal is to make s…
Matched conditions: SYSTEMIC SCLEROSIS (SSC)
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC